Atlas Trials

Effects of CX516 on Functioning in Fragile X Syndrome and Autism

Clinical trial NCT00054730 · COMPLETED

Trial details

NCT number
NCT00054730
Sponsor
RespireRx
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Fragile X SyndromeAutism
Start date
2002-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.